Latest Production Expansion News

Sayona Mining reports a 124% surge in Ore Reserves at its North American Lithium operation, alongside an 8% Mineral Resource increase, reinforcing its position in the North American lithium market.

SiteMinder Limited reported a 17.7% revenue increase to $224.3 million in FY2025, alongside a reduced net loss and positive underlying EBITDA, driven by its innovative Smart Platform strategy and expanding customer base.

Cash Converters International Limited reported robust FY25 results, driven by strategic franchise acquisitions and a shift to longer-term, lower-cost lending products. The company is poised for further growth with new loan launches and luxury retail expansion.

Star Combo Pharma has reported a remarkable jump in profit for FY2025, driven by strong revenue growth and a settled insurance claim, while declaring its second dividend and planning production expansion.

Beforepay Group Limited reported a robust 74% jump in net profit for FY25, driven by stronger advance volumes, improved credit quality, and expanding user base. Its AI-powered lending division, Carrington Labs, accelerated growth with new clients and strategic partnerships.

GQG Partners Inc. reported robust first-half 2025 results with revenue up 11% and net income rising 14.4%, alongside a new US ETF launch and a declared interim dividend.

Lindian Resources has raised A$91.5 million through a strong institutional placement, enabling the final investment decision for the Kangankunde Rare Earths Project’s Stage 1 development with production targeted for late 2026.

Orezone Gold Corporation reveals promising high-grade drill results beneath existing pits at its Bomboré Gold Mine, highlighting potential for significant resource expansion and production increase.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

REA Group has appointed Cameron McIntyre as its new CEO, succeeding Owen Wilson who will retire from full-time executive duties. McIntyre’s proven leadership in digital marketplaces positions him to steer REA’s expansion and innovation.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.